LEEF:CA:CNSX-Leef Brands Inc. (CAD)

COMMON STOCK | Drug Manufacturers - Specialty & Generic |

Last Closing

USD 0.265

Change

0.00 (0.00)%

Market Cap

USD 0.05B

Volume

0.14M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Leef Brands Inc. operates as a cannabis branded products manufacturer in the United States. It provides resins and infused pre-rolls. The company offers its products under the Ganja Gold, Real Deal Resin, Heady, and LEEF brand names. The company was formerly known as Icanic Brands Company Inc. and changed its name to Leef Brands Inc. in December 2022. Leef Brands Inc. is headquartered in Vancouver, Canada.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-08 )

Largest Industry Peers for Drug Manufacturers - Specialty & Generic

Symbol Name Price(Change) Market Cap
GTII:CA Green Thumb Industries Inc

-0.77 (-6.66%)

USD 2.72B
TRUL:CA Trulieve Cannabis Corp

-0.24 (-3.19%)

USD 1.31B
CL:CA Cresco Labs Inc

-0.09 (-6.12%)

USD 0.41B
GRIN:CA Grown Rogue International Inc

-0.01 (-1.10%)

USD 0.20B
PLTH:CA Planet 13 Holdings Inc

-0.01 (-1.85%)

USD 0.17B
AAWH-U:CA Ascend Wellness Holdings Inc.

-0.04 (-8.70%)

USD 0.09B
JUSH:CA Jushi Holdings Inc

-0.01 (-1.16%)

USD 0.08B
MRMD:CA MariMed Inc.

+0.01 (+3.13%)

USD 0.07B
AYR-A:CA Ayr Wellness Inc

-0.07 (-9.46%)

USD 0.07B
INNO:CA InnoCan Pharma Corporation

N/A

USD 0.06B

ETFs Containing LEEF:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers - Specialty & Generic) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -11.67% 19% F 19% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -11.67% 19% F 19% F
Trailing 12 Months  
Capital Gain 32.50% 84% B 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 32.50% 84% B 77% C+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -10.94% 46% F 37% F
Dividend Return -10.94% 46% F 37% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 35.33% 75% C 61% D-
Risk Adjusted Return -30.96% 40% F 43% F
Market Capitalization 0.05B 84% B 95% A

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.